Zhigang Yuan

Zhigang Yuan

Auto-generated profile, based on publicly available information

Zhigang Yuan

Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2007 in Cell Cycle
Verified
Journal Article
Open access
ZYZhigang Yuan
Zhigang Yuan
ESEdward Seto
Edward Seto
In mammalian cells, DNA is often subjected to stresses such as ionizing radiation (IR) and ultraviolet light that can induce DNA double strand breaks (DSBs). In response to DNA DSBs, mammalian cell...

9 May 2020 in Journal of Medical Imaging and Radiation Oncology
Verified
Journal Article
Closed access
PDF file
ZYZhigang Yuan
Zhigang Yuan
MFMarissa Frazer
Marissa Frazer
GZGeoffrey G Zhang
Geoffrey G Zhang
KLKujtim Latifi
Kujtim Latifi
EMEduardo G Moros
Eduardo G Moros
JFJessica Frakes
Jessica Frakes

20 July 2020 in Future Oncology
Verified
Journal Article
Closed access
ZYZhigang Yuan
Zhigang Yuan
MFMarissa Frazer
Marissa Frazer
KAKamran A Ahmed
Kamran A Ahmed
SNSyeda Mahrukh Hussnain Naqvi
Syeda Mahrukh Hussnain Naqvi
MSMichael J Schell
Michael J Schell
JFJessica Frakes
Jessica Frakes
Aim: Genomic-based risk stratification to personalize radiation dose in rectal cancer. Patients & methods: We modeled genomic-based radiation dose response using the previously validated radiosensi...

1 November 2020 in JCO Global Oncology
Verified
Journal Article
Open access
FAFrancis Adumata Asamoah
Francis Adumata Asamoah
JYJoel Yarney
Joel Yarney
ASAba Scott
Aba Scott
VVVerna Vanderpuye
Verna Vanderpuye
ZYZhigang Yuan
Zhigang Yuan
KAKamran Ahmed
Kamran Ahmed
Cervical cancer remains a major health challenge in low- to middle-income countries. We present the experiences of two centers practicing in variable resource environments to determine predictors of improved radiochemotherapy treatment. This comparative review describes cervical cancer presentation and treatment with concurrent chemoradiotherapy with high-dose-rate brachytherapy between 2014 and 2017 at the National Radiotherapy Oncology and Nuclear Medicine Center (NRONMC) in Korle-Bu Teaching Hospital, Accra, Ghana, and Moffitt Cancer Center (MCC), Tampa, FL. Median follow-up for this study was 16.9 months. NRONMC patients presented with predominantly stage III disease (42% v 16%; P = .002). MCC patients received para-aortic node irradiation (16%) and interstitial brachytherapy implants (19%). Median treatment duration was longer for NRONMC patients compared with MCC patients (59 v 52 days; P < .0001), and treatment duration ≥ 55 days predicted worse survival on multivariable analysis (MVA; P = .02). Stage ≥ III disease predicted poorer local control on MVA. There was a difference in local control among patients with stage III disease (58% v 91%; P = .03) but not in survival between MCC and NRONMC. No significant difference in local control was observed for stage IB, IIA, and IIB disease. Although there were significant differences in disease presentation between the two centers, treatment outcomes were similar for patients with early-stage disease. Longer treatment duration and stage ≥ III disease predicted poor outcomes.

16 September 2013 in HEREDITAS
Verified
Journal Article
Open access
RCRong-Ni Chang
Rong-Ni Chang
GYGuang-Zhi Yuan
Guang-Zhi Yuan
JTJian-Qiang Tan
Jian-Qiang Tan
QLQing-Niao Lai
Qing-Niao Lai
JMJun Ma
Jun Ma
ZYZhi-Gang Yuan
Zhi-Gang Yuan
Autosomal dominant cerebellar ataxias (ADCAs) comprise a group of genetically heterogeneous neurodegenerative disorders among which spinocerebellar ataxia type 3 (SCA3) represents the most common form of SCAs worldwide. The fragments of SCA3/MJD gene,which is the member of family GXPL1,were amplified by polymerase chain reaction (PCR). The PCR products of SCA3/MJD gene were detected with capillary electrophoresis (CE) and sequencing to evaluate the size of CAG repeats, feature in the transmission and the mutation in the family with SCA3 in Guangxi province. The results showed that the exon 10 of the SCA3/MJD gene contains 64-71 CAG repeats in all of the affected individuals and three asymptomatic carriers of the family. The number of the CAG repeats during transmission in the normal individuals carrying CGG allele remains consistent, suggesting that CGG allele could have no effect on intergenerational stability of CAG repeats in normal individuals. In addition, two novel point mutations were identified: IVS9-113 T > C in the intronic region and a missense mutation 220 G > A (Glu > Gly) in the encoding region. These two novel point mutations have not been reported and the effect of the mutations on the phenotype of SCA3 is not clear.